ArticleJournal of inflammation research2022

KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case-Control Study.

Yu-Hsiang Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.